
Nauzer Forbes
Articles
-
Oct 5, 2024 |
onlinelibrary.wiley.com | Nauzer Forbes |Jackie Bosch |John Eikelboom
Dear Editors, We thank Dr. Yang et al. for their interest in our study [1]. In their letter [2], they suggested that our analysis of the incidence and predictors of major gastrointestinal bleeding in patients on aspirin 100 mg once daily, rivaroxaban 5 mg twice daily or the combination of aspirin 100 mg once daily and rivaroxaban 2.5 mg twice daily had ‘critical’ limitations [1]. First, they suggested that we ‘neglected’ to report long-term outcomes after major acute bleeding.
-
Apr 14, 2023 |
gastrojournal.org | Nauzer Forbes
Lau JYW, Li R, Tan C, et al. Comparison of Over-the-Scope Clips to Standard Endoscopic Treatment as the Initial Treatment in Patients With Bleeding From a Nonvariceal Upper Gastrointestinal Cause. Ann Int Med 2023; online ahead of print. DISCLOSURES/ CONFLICTS OF INTEREST:Nauzer Forbes is a consultant for and has received speaker’s fees from Pentax Medical and Boston Scientific, is a consultant for Astra Zeneca, and has received research funding from Pentax Medical.
-
Mar 6, 2023 |
gastrojournal.org | Nauzer Forbes
Heisser T, Kretschmann J, Hagen B, et al. Prevalence of Colorectal Neoplasia 10 or More Years After a Negative Screening Colonoscopy in 120 000 Repeated Screening Colonoscopies. JAMA Intern Med 2023; online ahead of print: DOI 10.1001/jamainternmed.2022.6215. Nauzer Forbes is a consultant for and has received speaker’s fees from Pentax Medical and Boston Scientific, is a consultant for Astra Zeneca, and has received research funding from Pentax Medical.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →